Skip to content

T-cell activation means lower CD4 gains in HAART treated HIV patients

Switch from d4T to abacavir gives `modest` fat gains

HIV doctors should be actively involved in prevention initiatives - but is this realistic?

MSF highlights need for cheaper paediatric drugs in global ARV price survey

Talking about side-effects

HIV-positive boys and girls enter puberty later

Low albumin levels predict death in HIV-positive women, even if taking HAART

Low creatinine clearance reported greater risk for lactic acidosis than any HIV drug

HAART has improved mental health of HIV patients, even those not on treatment